Daniel Podzamczer

机构：Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Hospital Universitari Germans Trias i Pujol, Fundació Lluita contra les Infeccions

发表论文 68 篇 · 总被引 3519 次 · h-index 27

代表论文

• Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study (2019 · The Lancet · 被引 1016)
• Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain (2020 · Clinical Microbiology and Infection · 被引 423)
• Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study (2021 · The Lancet Infectious Diseases · 被引 104)
• Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021 · The Lancet HIV · 被引 91)
• Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort (2021 · Clinical Microbiology and Infection · 被引 50)
• Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV–1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58) (2020 · Clinical Infectious Diseases · 被引 21)